{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T22:05:40Z","timestamp":1789250740208,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"European funding for regional development","award":["PROJ-00832"],"award-info":[{"award-number":["PROJ-00832"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s10096-020-04061-w","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T21:02:19Z","timestamp":1602104539000},"page":"591-595","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Trichomonas vaginalis including relevant resistance-associated mutations in a single center in the Netherlands"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4203-3858","authenticated-orcid":false,"given":"R. H. T.","family":"Nijhuis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. G.","family":"Duinsbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. C. R.","family":"Godschalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"key":"4061_CR1","unstructured":"National multidisciplinar guideline for STIs (in Dutch). Accessed 22\u201301- 2020, https:\/\/www.soaaids.nl\/files\/2020-01\/mdr-multidisciplinaire-richtlijn-soa-2018-update-2019-versie-oktober-2019.pdf"},{"key":"4061_CR2","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1177\/0956462415596496","volume":"27","author":"AS de Jong","year":"2016","unstructured":"de Jong AS, Rahamat-Langendoen JC, van Alphen P, Hilt N, van Herk C, Pont S, Melchers W, van de Bovenkamp J (2016) Large two-centre study into the prevalence of Mycoplasma genitalium and Trichomonas vaginalis in the Netherlands. Int J STD AIDS 27:856\u2013860","journal-title":"Int J STD AIDS"},{"key":"4061_CR3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/23744235.2017.1290271","volume":"49","author":"ML Jenniskens","year":"2017","unstructured":"Jenniskens ML, Veerbeek JH, Deurloo KL, van Hannen EJ, Thijsen SF (2017) Routine testing of Mycoplasma genitalium and Trichomonas vaginalis. Infect Dis (Lond) 49:461\u2013465","journal-title":"Infect Dis (Lond)"},{"key":"4061_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/sextrans-2015-052118","volume":"92","author":"C van der Veer","year":"2016","unstructured":"van der Veer C, van Rooijen MS, Himschoot M, de Vries HJ, Bruisten SM (2016) Trichomonas vaginalis and Mycoplasma genitalium: age-specific prevalence and disease burden in men attending a sexually transmitted infections clinic in Amsterdam, the Netherlands. Sex Transm Infect 92:83\u201385","journal-title":"Sex Transm Infect"},{"key":"4061_CR5","unstructured":"Staritsky L, Van Aar F, Visser M, Op de Coul E, Heijne J, Gotz H, Nielen M, Van Sighem A, Van Benthem B (2020) Surveillance report: sexually transmitted infections in the Netherlands in 2019. https:\/\/www.rivm.nl\/bibliotheek\/rapporten\/2020-0052.pdf"},{"key":"4061_CR6","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1111\/jdv.13849","volume":"30","author":"JS Jensen","year":"2016","unstructured":"Jensen JS, Cusini M, Gomberg M, Moi H (2016) 2016 European guideline on Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol 30:1650\u20131656","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4061_CR7","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1093\/jac\/dkw584","volume":"72","author":"JF Braam","year":"2017","unstructured":"Braam JF, Slotboom B, Van Marm S, Severs TT, Van Maarseveen NM, Van Zwet T, Boel ECH, Berkhout H, Hagen F, Van De Bovenkamp JHB, Van Dommelen L, Kusters JG (2017) High prevalence of the A2058T macrolide resistance-associated mutation in Mycoplasma genitalium strains from the Netherlands. J Antimicrob Chemother 72:1529\u20131530","journal-title":"J Antimicrob Chemother"},{"key":"4061_CR8","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.3201\/eid2507.181556","volume":"25","author":"L Martens","year":"2019","unstructured":"Martens L, Kuster S, de Vos W, Kersten M, Berkhout H, Hagen F (2019) Macrolide-resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014-2017. Emerg Infect Dis 25:1297\u20131303","journal-title":"Emerg Infect Dis"},{"key":"4061_CR9","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1093\/jac\/dkv136","volume":"70","author":"RH Nijhuis","year":"2015","unstructured":"Nijhuis RH, Severs TT, Van der Vegt DS, Van Zwet AA, Kusters JG (2015) High levels of macrolide resistance-associated mutations in Mycoplasma genitalium warrant antibiotic susceptibility-guided treatment. J Antimicrob Chemother 70:2515\u20132518","journal-title":"J Antimicrob Chemother"},{"key":"4061_CR10","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s10096-017-2969-9","volume":"36","author":"JF Braam","year":"2017","unstructured":"Braam JF, van Dommelen L, Henquet CJM, van de Bovenkamp JHB, Kusters JG (2017) Multidrug-resistant Mycoplasma genitalium infections in Europe. Eur J Clin Microbiol Infect Dis 36:1565\u20131567","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4061_CR11","unstructured":"De Jong AS, Lestrade B, Broeren, M. A. P. M., Vet JAM, Rahamat-Langendoen JC, Trienekens TAM (EV0194, ePoster ECCMID 2017) Real-time PCR for routine first-line STI screening of Mycoplasma genitalium resistance against macrolide antibiotics"},{"issue":"2","key":"4061_CR12","doi-asserted-by":"crossref","first-page":"e01478","DOI":"10.1128\/JCM.01478-19","volume":"58","author":"C Le Roy","year":"2020","unstructured":"Le Roy C, Bebear C, Pereyre S (2020) Clinical evaluation of three commercial PCR assays for the detection of macrolide resistance in Mycoplasma genitalium. J Clin Microbiol 58(2):e01478\u2013e01419","journal-title":"J Clin Microbiol"},{"key":"4061_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/OLQ.0000000000001141","volume":"47","author":"J de Korne-Elenbaas","year":"2020","unstructured":"de Korne-Elenbaas J, Pol A, Vet J, Dierdorp M, van Dam AP, Bruisten SM (2020) Simultaneous detection of Neisseria gonorrhoeae and Fluoroquinolone resistance mutations to enable rapid prescription of oral antibiotics. Sex Transm Dis 47:238\u2013242","journal-title":"Sex Transm Dis"},{"key":"4061_CR14","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1128\/JCM.42.2.683-692.2004","volume":"42","author":"JS Jensen","year":"2004","unstructured":"Jensen JS, Bjornelius E, Dohn B, Lidbrink P (2004) Use of TaqMan 5\u2032 nuclease real-time PCR for quantitative detection of Mycoplasma genitalium DNA in males with and without urethritis who were attendees at a sexually transmitted disease clinic. J Clin Microbiol 42:683\u2013692","journal-title":"J Clin Microbiol"},{"key":"4061_CR15","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1128\/JCM.00579-17","volume":"55","author":"C Le Roy","year":"2017","unstructured":"Le Roy C, Pereyre S, Henin N, Bebear C (2017) French prospective clinical evaluation of the Aptima Mycoplasma genitalium CE-IVD assay and macrolide resistance detection using three distinct assays. J Clin Microbiol 55:3194\u20133200","journal-title":"J Clin Microbiol"},{"key":"4061_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.cmi.2017.09.006","volume":"24","author":"M Unemo","year":"2018","unstructured":"Unemo M, Salado-Rasmussen K, Hansen M, Olsen AO, Falk M, Golparian D, Aasterod M, Ringlander J, Nilsson CS, Sundqvist M, Schonning K, Moi H, Westh H, Jensen JS (2018) Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016. Clin Microbiol Infect 24:533\u2013539","journal-title":"Clin Microbiol Infect"},{"key":"4061_CR17","doi-asserted-by":"publisher","first-page":"5653","DOI":"10.1128\/JCM.43.11.5653-5659.2005","volume":"43","author":"CW Geraats-Peters","year":"2005","unstructured":"Geraats-Peters CW, Brouwers M, Schneeberger PM, van der Zanden AG, Bruisten SM, Weers-Pothoff G, Boel CH, van den Brule AJ, Harmsen HG, Hermans MH (2005) Specific and sensitive detection of Neisseria gonorrhoeae in clinical specimens by real-time PCR. J Clin Microbiol 43:5653\u20135659","journal-title":"J Clin Microbiol"},{"key":"4061_CR18","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/14737159.2017.1360137","volume":"17","author":"V Dona","year":"2017","unstructured":"Dona V, Low N, Golparian D, Unemo M (2017) Recent advances in the development and use of molecular tests to predict antimicrobial resistance in Neisseria gonorrhoeae. Expert Rev Mol Diagn 17:845\u2013859","journal-title":"Expert Rev Mol Diagn"},{"key":"4061_CR19","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1177\/0956462419825948","volume":"30","author":"S Soni","year":"2019","unstructured":"Soni S, Horner P, Rayment M, Pinto-Sander N, Naous N, Parkhouse A, Bancroft D, Patterson C, Fifer H (2019) British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium (2018). Int J STD AIDS 30:938\u2013950","journal-title":"Int J STD AIDS"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-04061-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-020-04061-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-04061-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T03:17:07Z","timestamp":1633576627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-020-04061-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["4061"],"URL":"https:\/\/doi.org\/10.1007\/s10096-020-04061-w","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,7]]},"assertion":[{"value":"6 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The medical research involving human subjects act (WMO) does not apply to this study as concluded by the Medical Research Ethics Committees United (MEC-U, Nieuwegein, the Netherlands).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable. A patient and corresponding diagnostic data was included only if the patient had not specifically indicated that sample material and data could not be used for other purposes than diagnosis of disease, as regulated by law and stated in \u201cHuman tissue and medical research: code of conduct for responsible use\u201d (2011).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}